Filter Results
:
(7,927)
Show Results For
-
All HBS Web
(7,927)
- People (21)
- News (2,595)
- Research (3,998)
- Events (16)
- Multimedia (274)
- Faculty Publications (3,259)
Show Results For
-
All HBS Web
(7,927)
- People (21)
- News (2,595)
- Research (3,998)
- Events (16)
- Multimedia (274)
- Faculty Publications (3,259)
- July–August 2013
- Article
The Network Secrets of Great Change Agents
By: Julie Battilana and Tiziana Casciaro
Change is hard, especially in a large organization. Yet some leaders succeed—often spectacularly—at transforming their workplaces. What makes them able to exert this sort of influence when the vast majority can't? The authors tracked 68 change initiatives in the UK's...
View Details
Battilana, Julie, and Tiziana Casciaro. "The Network Secrets of Great Change Agents." Harvard Business Review 91, nos. 7/8 (July–August 2013): 62–68.
- 14 Jul 2015
- First Look
First Look: July 14, 2015
case: https://cb.hbsp.harvard.edu/cbmp/product/215038-PDF-ENG Harvard Business School Case 615-052 Transforming Care at UnityPoint Health-Fort Dodge This case details the transformation of a health care delivery system, UnityPoint...
View Details
Keywords:
Sean Silverthorne
- January 2006 (Revised April 2007)
- Case
General Electric Healthcare, 2006
By: Tarun Khanna and Elizabeth Raabe
In January 2006, Joe Hogan, head of General Electric (GE) Healthcare Technologies, prepared to step into William Castell's shoes as CEO of GE Healthcare, the world's leading manufacturer of diagnostic imaging equipment. In 2004, former CEO Jeff Immelt acquired Amersham...
View Details
Keywords:
Corporate Entrepreneurship;
Cost vs Benefits;
Growth and Development Strategy;
Mergers and Acquisitions;
Machinery and Machining;
Global Range;
Multinational Firms and Management;
Product Design;
Technological Innovation;
Expansion;
Value Creation;
Business Subsidiaries;
Health Industry;
Health Industry
Khanna, Tarun, and Elizabeth Raabe. "General Electric Healthcare, 2006." Harvard Business School Case 706-478, January 2006. (Revised April 2007.)
- December 2014 (Revised July 2016)
- Case
HEINEKEN—Brewing a Better World
By: Forest L. Reinhardt, José Alvarez, Tonia Junker and Daniela Beyersdorfer
The Dutch company HEINEKEN, one of the leading global brewers known for its brands like Heineken, Amstel, and Desperados and for its award-winning marketing campaigns, seeks to closely integrate its long-term sustainability "Brewing a Better World" approach into its...
View Details
Keywords:
Beer/brewing Industry;
Sustainability;
Local Sourcing;
Corporate Strategy;
Global Strategy;
Brands and Branding;
Marketing Strategy;
Supply Chain Management;
Corporate Social Responsibility and Impact;
Food and Beverage Industry
Reinhardt, Forest L., José Alvarez, Tonia Junker, and Daniela Beyersdorfer. "HEINEKEN—Brewing a Better World." Harvard Business School Case 715-022, December 2014. (Revised July 2016.)
- 09 Oct 2017
- Working Paper Summaries
Habit Formation and Rational Addiction: A Field Experiment in Handwashing
- 04 Jan 2019
- News
Beyond the bottom line: should business put purpose before profit?
- 28 Feb 2013
- News
Q&A: Charlie Rose Talks to Harvard's Michael Porter
- 05 Aug 2020
- News
Remote work really does mean longer days -- and more meetings
- 29 Jun 2012
- News
Mass. residents react to ruling with relief
- 19 Jan 2012
- News
Enlightened eating
- 2024
- Working Paper
HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how a diverse cast of characters, including public health organizations, research laboratories, for-profit healthcare companies, activists, and regulators, rolled back the outbreak of HIV/AIDS in just fifteen years. Moreover, as the case...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Innovation Strategy;
Technology Adoption;
Collaborative Innovation and Invention;
Innovation and Invention;
Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-007, July 2019. (Revised May 2024.)
- Article
Adding Value by Talking More
By: Robert S. Kaplan, Derek A. Haas and Jonathan Warsh
The prevailing fee-for-service payment model has led health care administrators and physician practices to impose severe constraints on the time physicians spend talking, for which they are reimbursed poorly or not at all. New value-based reimbursement models, however,...
View Details
Keywords:
Value Creation;
Cost Management;
Health Care and Treatment;
Customer Focus and Relationships;
Health Industry
Kaplan, Robert S., Derek A. Haas, and Jonathan Warsh. "Adding Value by Talking More." New England Journal of Medicine 375, no. 20 (November 17, 2016): 1918–1920.
- 08 May 2018
- First Look
First Look at New Research and Ideas, May 8, 2018
improve pediatric care, and address the challenges posed by a rapidly changing health care environment. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/718420 Harvard Business School Case 118-028 Summa Equity: Building...
View Details
Keywords:
Sean Silverthorne
Healthy Buildings: What Will We Measure and How Will We Know?
Three irreversible trends -- realization of the deep downside of bad public health and bad buildings; the access to and democratization of air quality data; and the relaxation of the need to be present in-person, face-to-face, day-to-day -- will forever change...
View Details
- Program
Senior Executive Program—Africa
organization during the program. Review Our Campus Health & Safety Protocols Read More Both case-based formats are led by HBS faculty, who share their latest research and engage you in a dynamic exchange of ideas with a global community...
View Details
- 29 Apr 2020
- News
What Makes an Office Building “Healthy”
- 02 Aug 2019
- News
Will there be 2020 foresight regarding America's skills dilemma?
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
Keywords:
Mergers and Acquisitions;
Value;
Valuation;
Judgments;
Decision Making;
Cash Flow;
Financial Instruments;
Cognition and Thinking;
Pharmaceutical Industry;
Biotechnology Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.